Paul Gama, P&G CEO-health care, sells $477,510 in stock
Procter & Gamble CEO Paul Gama sold $477,510 worth of the company's shares on October 30, 2026. He traded 2,894 shares at $165.00 each, leaving him with 43,898.8803 shares directly and 1,183.969 shares indirectly held through a retirement plan. Procter & Gamble has been busy in financial markets, issuing €3.25 billion in senior notes in four tranches maturing from 2030 to 2046 and a $4 billion offering extending to 2056.
Analysts have revised their outlooks, with Piper Sandler and TD Cowen raising price targets to $167 and $166, respectively, citing strong performance. Morgan Stanley boosted its target to $185, highlighting 6% profit and earnings per share upside, as organic sales outpaced expectations by 4.0%.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
